MedTrace Logo

Naproxen on Tooth Sensitivity Caused by In-office Bleaching

NCT02463552 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-10-26

No results posted yet for this study

Summary

This study aims to evaluate the effects of prior use of non-steroidal anti-inflammatory Naproxen on risk and level of tooth sensitivity caused by in-office bleaching procedures.

Conditions

  • Toothache
  • Tooth Bleaching

Interventions

DRUG

Naproxen

The patient will receive a single-dose of Naproxen (500 mg) one hour before the bleaching procedure.

Sponsors & Collaborators

  • Universidade Federal de Sergipe

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-06-30
Completion
2016-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02463552 on ClinicalTrials.gov